Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Title of publication: 

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Authors: 

Iwata H, Pipi E, Möckel N, Sondermann P, Vorobyev A, van Beek N, Zillikens D, Ludwig RJ

Year of Publication: 

2014

medium resp. publishing house / place: 

J Invest Dermatol.

edition / issue: 

Mar 2015; Epub 20 / Oct 2014

Pages: 

916-919

related to project: